Guggenheim Macro Opportunities Fund Class C
Guggenheim Macro Opportunities Fund Class C
Fund · US40168W5904 · GIOCX (XNAS)
Overview
No Price
28.10.2025 12:09
Current Prices from Guggenheim Macro Opportunities Fund Class C
ExchangeTickerCurrencyLast TradePriceDaily Change
XNAS: NASDAQ
NASDAQ
GIOCX
USD
28.10.2025 12:09
25,00 USD
0,00 USD
Share Float & Liquidity
Free Float -
Shares Float -
Shares Outstanding 351,37 M
Company Profile for Guggenheim Macro Opportunities Fund Class C Fund
The investment seeks to provide total return, comprised of current income and capital appreciation. The fund invests in a wide range of fixed-income and other debt and equity securities selected from a variety of sectors and credit qualities, principally corporate bonds, syndicated bank loans and other direct lending opportunities, participations in and assignments of syndicated bank loans, asset-backed securities, U.S. government and agency securities, sovereign debt securities, Eurodollar bonds and obligations, mezzanine and preferred securities, commercial paper, zero-coupon bonds, municipal securities, etc.
Get up to date insights from finAgent about Guggenheim Macro Opportunities Fund Class C

Company Data

Name Guggenheim Macro Opportunities Fund Class C
Company Guggenheim Macro Opportunities Fund Class C
Symbol GIOCX
Primary Exchange XNAS NASDAQ
ISIN US40168W5904
Asset Class Fund
Sector Financial Services
Industry Asset Management
Market Capitalization 8 Mrd.
Country United States of America
Currency USD
Employees -
Address Guggenheim Investments,
IPO Date 2011-11-30
Dividends from 'Guggenheim Macro Opportunities Fund Class C'
Ex-Date Dividend per Share
28.06.2024 0,10 USD
31.05.2024 0,12 USD
30.04.2024 0,10 USD
28.03.2024 0,10 USD
31.01.2024 0,10 USD
29.12.2023 0,16 USD
30.11.2023 0,14 USD
31.10.2023 0,15 USD
29.09.2023 0,12 USD
31.08.2023 0,09 USD

Ticker Symbols

Name Symbol
NASDAQ GIOCX
More Shares
Investors who hold Guggenheim Macro Opportunities Fund Class C also have the following shares in their portfolio:
Chemical Industries (Far East) Limited
Chemical Industries (Far East) Limited Share
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Share
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025